Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Pharma Tech

Sino and AstraZeneca sign licence agreement for TQC3721

Jul 9, 2026, 9:48 AM

Read Full Article → Sino and AstraZeneca sign licence agreement for TQC3721

Sino and AstraZeneca sign licence agreement for TQC3721

Translate article text

Choose a language and wait for the translated text.

AstraZeneca and Sino Biopharmaceutical's subsidiary CTTQ have signed an exclusive licence agreement for TQC3721.

Sino and AstraZeneca sign licence agreement for TQC3721 | PharmaVoice